Nelson Laboratories will provide instruction on the necessary sterility assurance levels for medical devices at MD&M East June 10-12, 2014 at the Jacob K. Javits Convention Center in New York in booth number 1857.
Martell Winters, senior scientist at Nelson Laboratories, will present updates to sterilization and bioburden standards June 10 from 10:00 to 11:45 a.m. (in Track B, Technical Training Track 1). He will speak on the topic, Medical Device Sterilization: Selection of SAL, Evaluation of Bioburden Data, Alert and Action Levels and Bioburden Excursions. The presentation will help medical device manufacturers better understand sterility assurance and bioburden data.
"We will discuss the necessity of a 10-6 sterility assurance level, bioburden data, and establishing alert and action levels," says Winters. "This information is necessary for all forms of sterilization and products, but is especially pertinent for combination products, biologics, and tissues."
In addition, Winters will present, Updates to the Bioburden Standard ISO 11737-1; Significant Additional Guidance. P.S. What Happened to the Microbiologists?, in the Tech Theater June 11 at 12:40 to 1:10 p.m. (located in booth 479).
To register for the MD&M East conference, visit: http://www.canontradeshows.com/expo/east14/conference_comp.html
Source: Nelson Laboratories
How Cleaning Medical Equipment Directly Affects Patient Safety and Equipment Longevity
September 16th 2024Hospital-associated infections affect over 1 million US patients annually. Proper medical equipment cleaning and sterilization significantly reduce infection risks, improving patient outcomes and safety.
New UV-C Disinfection Technology for Ultrasound Probes Earns FDA Clearance
September 4th 2024Chronos, a chemical-free UV-C disinfection device for ultrasound probes, received FDA clearance. It offers health care professionals a fast, automated solution to reduce cross-contamination and improve infection prevention.
Addressing Sterile Processing Instrument Errors With Advanced Technology and Data Insights
September 3rd 2024Surgical instrument errors, often linked to visualization failures during sterile processing, pose significant risks to patient safety and OR efficiency. Advanced technologies, including AI, are essential for reducing these errors and improving overall outcomes in sterile processing departments.
Implementing FDA 21 CFR Part 820 & ISO 13485 on Quality System Regulation
August 30th 2024The FDA's 21 CFR Part 820 and ISO 13485 are crucial in regulating medical device quality systems. Harmonizing these standards by 2026 will streamline compliance, improve patient access to devices, and align US regulations with global practices.